I want to thank Dr. Smith for appearing before the committee today.
I have a couple of questions with regard to the state of clinical trials in Canada, and perhaps you could speak to UHN's own experience and how it relates to COVID-19. Are you seeing that collaboration that you spoke about in the way that clinical trials could eventually work in Canada without compromising, obviously, patient safety? Do you see innovation within that system that could get to a vaccine faster?